Industry focus: Healthcare and life sciences

Quinz

Client Satisfaction

Quinz‘s practice stands out for its strong transactional and regulatory capabilities, often advising on transparency regulations, healthcare compliance matters, and competition issues. Olivier Van Obberghen has a solid track record in handling pharma compliance work and supply chain projects; he co-heads the practice with Pieter Wyckmans, who is well versed in advising on market access issues and pricing and reimbursement work. International research collaboration matters form a key pillar of Michiel D’herde's practice, and Marion Lapage fields expertise in R&D outsourcing projects and distribution issues. Amber Cockx often advises on digital health matters, and Pauline Meskens focuses on market access and parallel imports issues.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘We work with Dries Vanpaemel and Amber Cockx. Dries is very experienced in contract law and covers a broad range of contracting capabilities (including supply/distribution). Amber provides great legal support on regulatory/compliance related matters. Both are well positioned to transfer legal requirements into practical solutions.’
‘Great team with great expertise and practical experience.’
‘What sets them apart is their unwavering dedication and sense of purpose. Their commitment to delivering excellence is evident in every engagement.’
‘Quinz’s support has always been flawless, straight to the point and perfectly tailored to my needs. Quinz is impressive in terms of its experience and expertise, as well as regarding its dedication for the life sciences sector that each individual team member clearly shows. Furthermore, they follow a holistic approach and clients highly profit from their multidisciplinary perspective on each project.’
‘Olivier Van Obberghen and Pieter Wyckmans are truly passionate about life sciences and are extremely reliable, experienced and knowledgeable. Pieter has an unequalled knowledge of the Belgian pricing and reimbursement landscape and is a brilliant and creative negotiator. Olivier is definitely the go-to person for healthcare compliance in Belgium and is a gifted and inspirational speaker on this subject. Furthermore, the whole team is super pleasant to work with.’
‘We work with Olivier Van Obberghen and Pieter Wyckmans, both of them are excellent and fantastic legal support in Belgium.’
‘Pieter Wyckmans and Olivier Van Obberghen are humble, but have deep experience, pushing back when needed, but looking for solutions where possible.'

Key clients

Johnson & Johnson
UCB Pharma
Takeda
Galapagos
Telix Pharmaceuticals
Vertex
Bayer
ExeVir
Abscint
Priothera
IPOPI
Sciensano
Precirix
Incyte
Gates Ventures
SunshineSmile
ATB Therapeutics
Novo Nordisk
Merck KGaA
Biogazelle
Hyloris
Febelco
BlueBirdBio
Grünenthal Pharma GmbH & Co. KG
ISA Pharmaceuticals
Federal Knowledge Center
BVI (PhysIOL)
Recordati
ObsEva
Avroxa
Pharma.be
CleanBiologics
Roche
Eli Lilly
Novartis
Oxyrane
SOBI
Syndesi Therapeutics
Synox
Seuss+
Clinops
TwoBridge Pharma
EISAI Pharma
Materialise
Vaccinopolis
Cell Matters
Ardena
Amyl Therapeutics
Pharvaris
Optimapharm
Croma-Pharma GmbH
Dokteronline
Kenvue
Galderma
MedTech Europe
NanoBay
NCardia
Owkin
E-health Ventures
Gimv
European Vaccine Initiative
TB Alliance
Astrivax
Terumo
Sarepta
Vifor
GE Healthcare
UCB Ventures
CD3
Ultragenyx
Apellis
Novadip
Regmed
Oncode
Boehringer Ingelheim

Work highlights

Represented Recordati in a dispute against parallel importer PI Pharma, involving the issue of parallel importers trading generic medicines under the brand name of an originator medicine.
Advised the Belgian governmental institution KCE on developing a roadmap for academic institutions and hospitals to manufacture and commercially launch advanced therapies under their own proprietary IP and marketing authorisation.
Assisted Vifor with a challenge to a disproportional price decrease of Vifor’s Injectafer® product.